| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.028 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |